BioAnaLab moves to larger premises BioAnaLab receives GMP accreditation from MHRA BioAnaLab appoints David Oxlade as Chair of the Board of Directors BioAnaLab achieves full membership of the UK Good Laboratory Practice Compliance Programme BioAnaLab raises new investment to expand its analytical services BioAnaLab announces an eight-fold increase in turnover during the second year of operation BioAnaLab appoints Geoff Hale as CEO BioAnaLab wins Best New Start-up Laboratory at the Laboratory News Industry Awards BioAnaLab moves into new premises at the Magdalen Centre, Oxford Science Park ILEX(tm) Oncology, Inc. (Nasdaq: ILXO) has agreed in principle to exclusively sublicense CAMPATH(tm)-related diagnostic testing rights for Europe, the Middle East and Israel to UK-based BioAnaLab Ltd. BioAnaLab Ltd. is launched